TRYPTOPHAN-2,3-DIOXYGENASE (ODER FRAGMENTE DAVON) ENTHALTENDE IMPFSTÖFFE

European patent · EP3193917 · In force

Register entry

Publication number
EP3193917
Application number
EP15774851
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Corrected
Filed
Sep 15, 2015
Published
Jul 26, 2017
Granted
Aug 18, 2021
Protection ends at the latest
Sep 14, 2035
Next annual fee due
Sep 30, 2026
IPC classes
A61K 39/00 (2006.01)
Priority
DK 201470571 17.09.2014
PCT application
PCT/DK2015/050274 15.09.2015
PCT publication
WO2016/041560 24.03.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2025

    Change

    Published in Swissreg on 01.10.2025

  2. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  3. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  4. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  5. Jun 29, 2022

    Change

    Published in Swissreg on 29.06.2022

  6. Jan 19, 2022

    Change

    Published in Swissreg on 19.01.2022

  7. Nov 10, 2021

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 10.11.2021

  8. Aug 18, 2021

    Granted

    Published in Swissreg on 18.08.2021

Parties

Holder

IO Biotech APS

IO Biotech ApS

Ole Maaløes Vej 3, 2200 Copenhagen N, DK

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

ANDERSEN, Mads Hald

DK-2850 Nærum, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.